Although atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are expressed in the tissue of ventricles of failing hearts, the localization and histopathological features of natriuretic peptide-expressing ventricular myocytes have not been clearly described. This study was designed to characterize the ventricular cardiomyocytes that express both natriuretic peptides in 19 patients with dilated cardiomyopathy (DCM). Immunohistochemistry and in situ hybridization for ANP and BNP were performed with left ventricular biopsy specimens. Peptide-expressing myocytes were examined by hematoxylin-eosin staining and desmin immunohistochemistry and by in situ hybridization to characterize the corresponding cells histopathologically. The distributicn ~ ~~~ ku, Tokyo 113, Japan.
Introduction
The recently discovered atrial or A-type natriuretic peptide (ANP), and brain or B-type natriuretic peptide (BNP) are synthesized primarily in cardiomyocytes (1, 16, 17) and contribute to cardiovascular homeostasis through their potent natriuretic, diuretic, and vasodilatory actions (18,20,22,32). Previous studies have shown that the expression of both peptides is augmented in the ventricles of patients with dilated cardiomyopathy (DCM), which is characterized by dilatation of ventricles and impairment of ventricular systolic function (27, 28, 37, 46) . Ventricular expression of both peptides is thought to be induced by pressure overload on the ventricular walls (9). In immunohistochemical studies, however, ANP expression was not uniformly detected in all of the ventricular myocytes of patients with DCM (3,7,15). This pattern of ANP expression cannot be fully explained by global stress to the myocardium, suggesting that other factors may trigger ANP expression in ventricular myocytes. Recent studies with BNP-specific antibodies have shown the distribution of BNP immunoreactivity in the atrium (12) and ventricles (11) . Although BNP immunoreactivity has been detected in ventricular tissue of failing hearts, BNP expression was not also uniformly detected in the ventricular myocytes, and this mechanism remains unclear.
It has been reported that myocytes of failing human hearts primarily show morphological and metabolic changes in cell components including myofilaments, cytoskeleton, mitochondria, and sarcoplasmic reticulum. Desmin, the intermediate filament of the cytoskeleton specific for muscle cells, is normally located in the 2-band and intercalated disk of myocytes (39), but this distribution is reportedly altered in myocytes of patients with cardiac hypertrophy and degeneration (29, 43) . Therefore, the distribution of desmin in the cytosol of cardiomyocytes may be a marker for morphological change in failing hearts.
The aims of this study were to examine the expression of ANP and BNP in normal and diseased ventricles by immunohistochemistry and in situ hybridization and to examine the localization and histopathological characteristics of peptide-expressing myocytes in the left ventricles of patients with DCM. 
Materials and Methods
Materials. Left ventricular (LV) endomyocardial biopsy specimens were obtained from 19 patients with DCM and from five autopsies of subjects with normal hearts. The specimens were fixed in Bouin's solution and embedded in paraffii for immunohistochemistry and hematoxylin+osin (HE) staining and were also fmd in 4% paraformaldehyde with 0.5% g l u d d ehyde and embedded in low-melting-point paraffin for in situ hybridization. To d e the specificity of antibodies and cRNA probes used for immunohistochemistry and in situ hybridization, respectively, we obtained right atrial (RA) tissues from some patients with normal hearts during cardiac surgery.
In patients with DCM, hypertrophy and degeneration of myocytes and interstitial fibrosis were found to some degree, and no abnormal findings were observed in patients with normal hearts.
Immunohistochemistry. Immunohistochemistry for ANP and BIG' was performed with two polyclonal rabbit antisera: anti-human ANP [l-281 (Peninsula Laboratories: Belmont, CA) and anti-human BNP [l-321 (SMI Bristol; Kanagawa, Japan), and the avidin-biotin complex (ABC) method was employed to visualize the positive cells as previously described (23) . Briefly, after inhibition of intrinsic peroxidase activity with 0.3% H202 in methanol for 30 min, the sections were pre-incubated with 5% normal goat serum for 30 min, followed by incubation with primary antibody diluted to the appropriate concentration in 1% bovine serum albumin (BSA) overnight at room temperature (RT). After washing in PBS three times, the Sections were incubated with biotin-conjugated anti-rabbit IgG (Vector Labs, Burlingame, CA) diluted 1500 in 1% BSA for 2 hr at RT. Peroxidase was visualized with 33-diaminobenzidine (DAB) and H202. Counterstaining was performed with hematoxylin. In control experiments we used normal rabbit serum in the place of the primary antibodies and we also immunoabsorbed the antisera. As previously described (13), the primary antibody was pre-incubated with the corresponding antigen (100 nmollml antisera) overnight. In addition, to examine crossreactivity between anti-ANP and anti-BNP antibodies, the anti-ANP antibodies were pre-incubated with BNP and vice versa (100 nmollml antisera). To investigate the histopathological features of natriuretic peptide-expressing myocytes in the W, we also performed HE staining and desmin immunostaining. Desmin staining was performed by the ABC method described above, except that the sections were refixed in acetone at -20°C for 20 min after deparaffhization, followed by staining with monoclonal mouse antibodies against desmin (Dakopatts; Glostrup, Denmark). We performed immunohistochemistry (ANP, BNP, and dcsmin) and HE staining in four mirror or consecutive sections.
RNA Probes and In Situ Hybridization. A 680 base pair (BP) fragment of human ANP cDNA (25), a 310 BP fragment of human BNP cDNA (34) produced by polymerase chain reaction (PCR), and a 761 BP fragment of human desmin cDNA (19) produced by PCR were cloned into Bluescript I1 vector (Suatagene; La ]oh, CA). Anti-sense and sense single-strand cRNA probes were synthesized with 35S-labeled UTP (NEN Boston, MA) using T7lT3 RNA polymerase (Ambion; Austin, Tacas). Biopsy specimens were fuced in 4% paraformaldehyde with 0.5% glutaraldehyde and embedded in low-melting-point paraffin. After deparaffinization in xylene, the sections were digested with 100 pglml proteinase K (Boehringer Mannheim, Mannheim, Germany) in 10 mM %is-HCI (pH 7.6) and 1 mM EDTA for 10 min at RT. The hybridization buffer contained 0.6 M NaCI, 1 mM EDTA, 10 mM Tiis-HC1 (pH 7.6), 10% dextran sulfate, 0.25% SDS, 200 p g l d tRNA, 1 x Denhardt's solution, 10 mM m, and 50% (vlv) deionized formamide. Fifty p1 of the hybridization buffer containing either the antisense or the sense cRNA probe was applied to each section, followed by incubation in a moist chamber with 2 x SSC and 50% formamide for 16 hr at )O' C. Then the sections were washed in 2 x SSC and 50% formamidc for 30 min at 50'C, followed by incubation with 20 pglml RNAse A (Boehringer Mannheim) for 30 min at 37%. After washing in 2 x SSC for 20 min and twice in 0.2 x SSC for 20 min at ) O X , the sections were dipped into the autoradiographic emulsion NTB 3 (Kodak, Rochester, NY) and were kept in light-tight boxes for 1-2 weeks. After photographic development, the sections were stained with HE. Three consecutive sections were examined by in situ hybridization of ANP, BNP, and desmin.
Results

Localization of ANP ana' BNP Immunoreactivity in Le8 Ventricle
It is well known that both ANP and BNP are synthesized and secreted abundantly in atrial myocytes (12). We therefore examined the specificity of anti-ANP and -BNP antibodies with atrial tissue from control subjects. Both ANP and BNP immunoreactivity were detected in the cytosol of atrial mygzes. Immunoreactive granules were easily distinguished from lipofuscin and were never observed in non-myocytes, fibroblasts, or vascular endothelial cells. After absorption of the antibody with the corresponding antigen, no immunoreactive staining was detected. Immunoreactivity was not diminished by pre-incubation of anti-ANP antibody with BNP or of anti-BNP antibody with ANP. No immunoreactivity was observed when normal rabbit serum was used as the primary antibody. These findings confirm the specificity of both antibodies.
Neither ANP nor BNP immunoreactivity was found in the LV myocytes of control hearts. In contrast, both ANP and BNP immunoreactivity were clearly detected in the LVs of patients with DCM. The number of ANPand BNP-positive myocytes was smaller in the LV than in the RA, and the positively stained granules in the LV were scattered throughout the myocyte cytosol. ANP-positive myocytes in the LV also showed BNP immunoreactivity ( Figures   1A and 1B ) and the distributions of ANP-and BNP-positive myocytes were almost identical in all DCM cases.
Although it has been shown that immunoreactivity for both peptides was found in almost all atrial myocytes, our results showed that ANP-and BNP-positive myocytes in LVs of patients with DCM showed distinct localization ( Figures 1C-1H ). Myocytes positive for both peptides were mainly located in the subendocardial layer, fibrous area, and perivascular region. This localization was confirmed by HE staining. In addition, peptide-expressing myocytes also had distinct characteristic morphological features, including hypertrophy with bizarre nuclei and/or loss of myofibrils.
In the LV specimens from control subject, weak desmin immunoreactivity was found on the 2band and strongly on the intercalated disk. In the LVs of patients with DCM, some myocytes that showed no morphological abnormality exhibited the same pattern of desmin staining as normal controls ( Figure 2C ). None of the myocytes with a normal desmin staining pattem exhibited ANP and BNP immunoreactivity (Figures 2A and 2B) . In contrast, the peptide-expressing myocytes of patients with DCM had a distinctly different pattern of desmin staining. In these myocytes, heavy deposits of desmin were strongly stained in the myocyte cytosol ( Figures 2D-2F ). and damin. In situ hybridization studies with each anti-sense RNA probe revealed strong ANP, BNP, and desmin mRNA signals in many RA myocytes (Figures 3A. 3C. and 3E) . In control acperiments using sense RNA probes, diffuse background labeling alone was observed over the sections (Figures 3B. 3D, and 3F) .
Locdization of ANP ana' BNP mRNAs
In addition to ANP and BNP immunoreactivity, ANP and BNP mRNA signals were found in some myocytes in the Ws of patients with DCM, whereas both peptide mRNA signals were never found in the Ws of control hearts. The myocytes that showed ANP mRNA signals also exhibited BNP mRNA signals (Figure 4) . i.e., the cellular distributions of ANP and BNP mRNA were almost identical, as were the distributions of ANP and BNP immunoreactivity. Myo- qtes expressing ANP and BNP "As were localized in the subendocardial layer and in the fibrous area, whereas neighboring areas were negative. We showed that the inuacellular distribution ofdesmin immunoreactivity was changed in the natriuretic peptideexpressing ventricular myocytes (Figure 2) . We compared the distribution 0 f~U i U m i~ peptide "As with that of dmnin "A. Figure 5 shows the dfirence between these distributions. Both ANP and BNP mRNA signals were concentrated intensely in the myocytes located in the subendocardial layer, whereas both signals were scvccly found in myocytes outside ofthe endocardium ( Figures   IA, SB, 5D, and 5E) . In contrast, desmin &A signals were homogeneously found in ventricular myocytes (Figures 5C and 5F) , and the desmin mRNA levels of the myocytes that showed abundant peptide mRNA signals were not greater than those of myo-cyte~ that were free of peptide mRNA signals.
Discussion
We have s h m by both immunohistochemisuy and in situ hybrid- ization that ANP and BNP expression in the LV augmented in patients with DCM and that the distributions of the two peptides were almost identical. Our data indicate that ANP and BNP expression in the LV might be coordinately induced. Several previous studies have detected natriuretic peptide expression in ventricles of patients with DCM and heart failure by immunohistochemistry (3,7,11,15 ). These reports, however, have described neither the differences in ANP and BNP expression nor the localization and characteristics of the peptide-expressing myocytes. In the present study, ANP and BNP expression was observed primarily in myocytes in the interstitial fibrous area, perivascular region, and subendocardium. This pattem of localized expression cannot be accounted for by global stress to the ventricular myocytes, as previously suggested on the basis of experiments with aortic coarctation in the rat (9). Although the mechanism underlying this localized expression is not understood, there are two possible explanations. One is a differential influence of local stress on ventricular myocytes in particular locations. Because the interstitial fibrous area is relatively resistant to contraction, myocytes in this area may undergo much more stretching than the myocytes in non-fibrous areas. This explanation may be supported by the observation of remodeling myo- cytes around ventricular aneurysms (10). The other possible explanation concerns the effect of the vasoactive substances and growth factors that are synthesized and secreted by cardiac fibroblasts and vascular endothelial cells in a paracrine manner. The synthesis and secretion of ANP in myocytes are stimulated by endothelin- 1  (8,21,24,30,33,41 ) and angiotensin I1 (35) in vivo and in vitro. It is postulated that endothelin and angiotensin, both of which have been found in the vessel wall (6,38), are synthesized in newly formed capillaries in the fibrous area. In preliminary studies, we also found that cardiac fibroblasts synthesize endothelin-1 in vitro (14). AIthough there is no direct evidence that myocytes and fibroblasts or vascular endothelial cells affect each other, cross-talk between myocytes and non-myocytes could result in the synthesis of natriuretic peptides in myocytes. Natriuretic peptides themselves might have autocrine or paracrine effects on myocytes, fibroblasts, and vascular endothelial cells, other than their known hormonal roles in natriuresis and vasodilatation. Both natriuretic peptides were expressed in a limited number of myocytes in subendocardium, whereas their mRNA transcripts were found in almost all cells of this region. Although this finding is very interesting, the discrepancy is not clearly understood. One possible explanation is that sensitivity of in situ hybridization for detection of mRNAs is much higher than that of the immunohistochemistry used in this study. Another possibility is that there is some difference between secretion rate of the proteins and tumover rate of their "As.
However. we are not aware of data to support these possibilities. ANP expression has been detected in ventricular myocytes from normal fetuses (31,44,45) . Diffuse distribution of desmin has also been found in myocytes from newborn rat ventricle ( 5 ) and in immature skeletal myocytes in vitro (42). This suggests that hypertrophied or damaged myocytes in adult patients are biochemically similar to fetal myocytes. The significance of these phenomena, however, remains unclear.
Previous studies have shown that Purkinje fibers produce ANP (2,4,40) . Therefore (36,43) . In diseased human myocardium the amount of desmin was increased and was irregularly distributed in myocytes (29). These changes in the concentration and localization of desmin may in part act to maintain the structural stability of myocytes. In the present study, we have shown that heavy deposits of desmin occurred in the cytosol of myocytes expressing natriuretic peptides. It is reasonable that natriuretic peptide expression, which has a compensatory effect on heart failure through its potent natriuresis and vasodilatation, is induced in damaged myocytes and is characterized by heavy deposits of desmin. From the results of immunohistochemistry of desmin, we hypothesized that the desmin mRNA levels should be augmented in myocytes with peptides mRNA augmentation. We have found that the desmin mRNA levels were homogeneous in ventricular myocytes of patients with DCM, whereas peptide mRNA and desmin mRNA levels were not always synchronous. Previous studies have shown that an increase in desmin mRNA expression took place on myogenesis (19,26). However, there have been few reports on desmin mRNA levels in failing hearts.
Our results indicate that desmin accumulation in damaged ventricular myocytes of DCM hearts is not usually associated with desmin mRNA augmentation, and further studies are needed concerning desmin mRNA levels in failing hearts.
In conclusion, the elevated expression of natriuretic peptides in LV is not induced solely by global stress to the myocardium but also appears to be influenced by regional conditions and humoral factors. Furthermore, the endocrine conversion of ventricular myocytes is associated with changes in myocyte architecture in patients with DCM.
